Ancillary care in Clinical Trials: time to conclude

[Guest guest]

Dear all,

I think the time to conclude has come.

The topic is of immense importance for the people who participate and for the researchers who perform research ethically.

Before closing the discussion,

I would like to give heartfelt thanks to Dr Henry for giving us some time from his very busy schedule. When I approached him, he was out of USA. He had only two days (15th and 16th Oct) for preparing for his next tour to AUS. Still, he guided us with the clarity, that I don’t think anyone will be able to do especially on this topic on AC.

Thank you sir.

Further I would like to thank Dr Santosh, Dr. Rakesh and Dr smita for lovely questions they raised to Henry, it made the discussion very interesting.

Also I would like to thank Dr Anupama and Mrs. Gharpure for putting forward their views on AC.

Finally I must thank Dr Vijay sir, for his efforts behind sending invitation to Dr. Henry, getting feed back and do all the things necessary for his participation.

And finally, I would like to thank all our readers too, who must have enjoyed and enriched with this newer concept of AC.

Regards,

Dr Kiran Chaudhari

Lecturer,

Dept of Pharmacology,

Govt Medical College,

Nagpur.440022Send free SMS to your Friends on Mobile from your Messenger. Download Now! http://messenger./download.php